UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Analysis of Oncogenic Signaling Networks in Glioblastoma Identifies ASPM as a Molecular Target

Proceedings of the National Academy of Sciences - PNAS, 2006-11, Vol.103 (46), p.17402-17407

2006

Volltextzugriff (PDF)

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

Nature medicine, 2004-06, Vol.10 (6), p.594-601

2004

Volltextzugriff (PDF)

Gene expression correlates of clinical prostate cancer behavior

Cancer cell, 2002-03, Vol.1 (2), p.203-209

2002

Volltextzugriff (PDF)

Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium

Clinical pharmacology and therapeutics, 2017-05, Vol.101 (5), p.589-592

2017

Volltextzugriff (PDF)

Successful whole-exome sequencing from a prostate cancer bone metastasis biopsy

Prostate cancer and prostatic diseases, 2014-03, Vol.17 (1), p.23-27

2014

Volltextzugriff (PDF)

Prostate Intraepithelial Neoplasia Induced by Prostate Restricted Akt Activation: The MPAKT Model

Proceedings of the National Academy of Sciences - PNAS, 2003-06, Vol.100 (13), p.7841-7846

2003

Volltextzugriff (PDF)

SP174 Gene signatures: Are we ready to change clinical management in cancer patient treatment?

European journal of cancer supplements, 2009, Vol.7 (4), p.3-3

Febbo, P

2009

Volltextzugriff (PDF)

Identification of CD15 as a Marker for Tumor-Propagating Cells in a Mouse Model of Medulloblastoma

Cancer cell, 2009-02, Vol.15 (2), p.135-147

2009

Volltextzugriff (PDF)

Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate

Annals of oncology, 2004-06, Vol.15 (6), p.974-978

2004

Volltextzugriff (PDF)

The V89L polymorphism in the 5α-reductase type 2 gene and risk of prostate cancer

Cancer research (Chicago, Ill.), 1999-12, Vol.59 (23), p.5878-5881

1999

Volltextzugriff (PDF)

1162P Tissue and liquid biopsy utilization in advanced NSCLC in a large community US practice

Annals of oncology, 2022-09, Vol.33, p.S1080

2022

Volltextzugriff (PDF)

No association between a polymorphic variant of the IRS-1 gene and prostate cancer risk

The Prostate, 2008-09, Vol.68 (13), p.1416-1420

2008

Volltextzugriff (PDF)

Carbonic Anhydrase IX Expression Predicts Outcome of Interleukin 2 Therapy for Renal Cancer

Clinical cancer research, 2005-05, Vol.11 (10), p.3714-3721

2005

Volltextzugriff (PDF)

No Association Between a Polymorphic Variant of the IRS-I Gene and Prostate Cancer Risk

The Prostate, 2008-09, Vol.68 (13), p.1416-1420

2008

Volltextzugriff (PDF)

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer

Cancer research (Chicago, Ill.), 2006-03, Vol.66 (5), p.2815-2825

2006

Volltextzugriff (PDF)

216 IDENTIFYING MECHANISMS OF RESISTANCE IN PATIENTS WITH LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER RECEIVING DOSE-DENSE NEOADJUVANT/INDUCTION CHEMOTHERAPY

Journal of investigative medicine, 2007-01, Vol.55 (1), p.S282

2007

Volltextzugriff (PDF)

A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis

Cancer epidemiology, biomarkers & prevention, 1997-03, Vol.6 (3), p.189

1997

Volltextzugriff (PDF)

Cancer gene profiling in prostate cancer

Methods in molecular biology (Clifton, N.J.), 2010-01, Vol.576, p.293

2010

Volltextzugriff (PDF)

Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors

Cancer research (Chicago, Ill.), 2005-06, Vol.65 (12), p.5054-5062

2005

Volltextzugriff (PDF)

HEALTH ECONOMIC IMPACT OF A 17-GENE PANEL PREDICTING AGGRESSIVE DISEASE IN MEN WITH NEWLY DIAGNOSED PROSTATE CANCER

Value in health, 2017-05, Vol.20 (5), p.A9

2017

Volltextzugriff (PDF)

Patterns of Gene Expression That Characterize Long-term Survival in Advanced Stage Serous Ovarian Cancers

Clinical cancer research, 2005-05, Vol.11 (10), p.3686-3696

2005

Volltextzugriff (PDF)

Debrisoquine hydroxylase (CYP2D6) and prostate cancer

Cancer epidemiology, biomarkers & prevention, 1998-12, Vol.7 (12), p.1075

1998

Volltextzugriff (PDF)

Neoadjuvant Docetaxel before Radical Prostatectomy in Patients with High-Risk Localized Prostate Cancer

Clinical cancer research, 2005-07, Vol.11 (14), p.5233-5240

2005

Volltextzugriff (PDF)

Timing and patterns of recurrences and deaths from prostate cancer following adjuvant pelvic radiotherapy for pathologic stage T3 4 adenocarcinoma of the prostate

Prostate cancer and prostatic diseases, 2006-09, Vol.9 (3), p.254-260

2006

Volltextzugriff (PDF)

A Prospectively-Designed Study to Determine the Association of a 17-Gene Genomic Prostate Score with Recurrence Following Surgery for Localised Prostate Cancer (Pca)

Annals of oncology, 2014-09, Vol.25, p.v1

2014

Volltextzugriff (PDF)

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(141)

Publikationsform

Sprache

Englisch
(161)
Italienisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Analysis of Oncogenic Signaling Networks in Glioblastoma Identifies ASPM as a Molecular Target

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

Gene expression correlates of clinical prostate cancer behavior

Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium

Successful whole-exome sequencing from a prostate cancer bone metastasis biopsy

Prostate Intraepithelial Neoplasia Induced by Prostate Restricted Akt Activation: The MPAKT Model

SP174 Gene signatures: Are we ready to change clinical management in cancer patient treatment?

Identification of CD15 as a Marker for Tumor-Propagating Cells in a Mouse Model of Medulloblastoma

Finasteride and bicalutamide as primary hormonal therapy in patients with advanced adenocarcinoma of the prostate

The V89L polymorphism in the 5α-reductase type 2 gene and risk of prostate cancer

1162P Tissue and liquid biopsy utilization in advanced NSCLC in a large community US practice

No association between a polymorphic variant of the IRS-1 gene and prostate cancer risk

Carbonic Anhydrase IX Expression Predicts Outcome of Interleukin 2 Therapy for Renal Cancer

No Association Between a Polymorphic Variant of the IRS-I Gene and Prostate Cancer Risk

Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer

216 IDENTIFYING MECHANISMS OF RESISTANCE IN PATIENTS WITH LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER RECEIVING DOSE-DENSE NEOADJUVANT/INDUCTION CHEMOTHERAPY

A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis

Cancer gene profiling in prostate cancer

Identification of a genetic signature of activated signal transducer and activator of transcription 3 in human tumors

HEALTH ECONOMIC IMPACT OF A 17-GENE PANEL PREDICTING AGGRESSIVE DISEASE IN MEN WITH NEWLY DIAGNOSED PROSTATE CANCER

Patterns of Gene Expression That Characterize Long-term Survival in Advanced Stage Serous Ovarian Cancers

Debrisoquine hydroxylase (CYP2D6) and prostate cancer

Neoadjuvant Docetaxel before Radical Prostatectomy in Patients with High-Risk Localized Prostate Cancer

Timing and patterns of recurrences and deaths from prostate cancer following adjuvant pelvic radiotherapy for pathologic stage T3 4 adenocarcinoma of the prostate

A Prospectively-Designed Study to Determine the Association of a 17-Gene Genomic Prostate Score with Recurrence Following Surgery for Localised Prostate Cancer (Pca)

Suchergebnisse filtern